Andreas Floersheimer

408 total citations
7 papers, 304 citations indexed

About

Andreas Floersheimer is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Andreas Floersheimer has authored 7 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Andreas Floersheimer's work include Chronic Lymphocytic Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Andreas Floersheimer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Andreas Floersheimer collaborates with scholars based in Switzerland, Germany and United States. Andreas Floersheimer's co-authors include Pascal Furet, Paul W. Manley, Gabriele Fendrich, Sandra W. Cowan‐Jacob, Gabriele Rummel, Doriano Fabbro, Janis Liebetanz, Terence O’Reilly, Michel Maira and Markus Wartmann and has published in prestigious journals such as Biochemistry, Cancer Research and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Andreas Floersheimer

7 papers receiving 295 citations

Peers

Andreas Floersheimer

MB

HEMAT

ONCOL

OC

GENET

Jeff Keats United States

Mairead Young United States

Harish Nagaraj Singapore

Charles Watson Moore United States

Yongping Xie China

Lesley Liu‐Bujalski United States

Liv Johannessen United States

Thorsten Gräf Germany

Jean Shearin United States

Frank Barbera United States

Jeff Keats United States

Andreas Floersheimer

131 ×1.0

MB

215 ×1.9

HEMAT

77 ×0.9

ONCOL

106 ×1.3

OC

133 ×1.9

GENET

Citations per year, relative to Andreas Floersheimer Andreas Floersheimer (= 1×) peers Jeff Keats

Countries citing papers authored by Andreas Floersheimer

Since Specialization

Citations

This map shows the geographic impact of Andreas Floersheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Floersheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Floersheimer more than expected).

Fields of papers citing papers by Andreas Floersheimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Floersheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Floersheimer. The network helps show where Andreas Floersheimer may publish in the future.

Co-authorship network of co-authors of Andreas Floersheimer

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Floersheimer. A scholar is included among the top collaborators of Andreas Floersheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Floersheimer. Andreas Floersheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jones, Matthew D., Philipp Grosche, Andreas Floersheimer, et al.. (2023). Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction. Biochemistry. 62(7). 1321–1329. 4 indexed citations

2.

Stauffer, Frédéric, Pascal Furet, Andreas Floersheimer, & Marc Lang. (2012). New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series. Bioorganic & Medicinal Chemistry Letters. 22(5). 1860–1863. 11 indexed citations

3.

Erdmann, Dirk, Bertrand Allard, Alain De Pover, et al.. (2009). Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins. 1(1). 80–84. 5 indexed citations

4.

O’Reilly, Terence, Markus Wartmann, Joseph Brueggen, et al.. (2008). Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 62(6). 1045–1054. 60 indexed citations

5.

Cowan‐Jacob, Sandra W., Gabriele Fendrich, Andreas Floersheimer, et al.. (2006). Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia. Acta Crystallographica Section D Biological Crystallography. 63(1). 80–93. 215 indexed citations

6.

Roesel, Johannes, Guido Bold, Josef Brueggen, et al.. (2005). Pharmacological profile of the FLT3-Tyrosine Kinase Inhibitor AST487. Cancer Research. 65. 1409–1409. 1 indexed citations

7.

Wartmann, Markus, Marc Hattenberger, Melanie Müller, et al.. (2004). Preclinical pharmacological profile of ABJ879, a novel epothilone B analog with potent and protracted anti-tumor activity. Cancer Research. 64. 1256–1256. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact